Share chart Venus Medtech (Hangzhou) Inc.
About Venus Medtech (Hangzhou) Inc.
Venus Medtech (Hangzhou) Inc. занимается исследованиями, разработками, клиническими разработками, производством и коммерциализацией медицинских устройств с транскатетерными сердечными клапанами в материковом Китае и за рубежом. more details| ISIN | CNE100003PJ8 |
|---|---|
| Industry | Health Care Equipment & Supplies |
| Sector | Health Care |
| Валюта | hkd |
| Валюта отчета | cny |
| Сайт | https://www.venusmedtech.com |
| Цена ао | 3.32 |
| Change price per day: | +48.21% (2.24) |
|---|---|
| Change price per week: | +72.92% (1.92) |
| Change price per month: | -40.93% (5.62) |
| Change price per 3 month: | -40.93% (5.62) |
| Change price per half year: | -40.93% (5.62) |
| Change price per year: | -40.93% (5.62) |
| Change price per 3 year: | -74.34% (12.94) |
| Change price per 5 year: | -92.49% (44.2) |
| Change price per year to date: | -40.93% (5.62) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Vanguard International Stock Index-Emerging Markets Stk | 3983500 | 0.9 |
| Vanguard International Stock Index-Total Intl Stock Indx | 3706377 | 0.84 |
| iShares Core MSCI Emerging Markets ETF | 2600500 | 0.59 |
| Fidelity Emerging Asia Fund | 2490882 | 0.56 |
| Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index | 1132000 | 0.26 |
| Fidelity Advisor Emerging Asia Fund | 1074577 | 0.24 |
| DFA Emerging Markets Core Equity Portfolio | 816500 | 0.19 |
| DFA Emerging Markets Small Cap Series | 743500 | 0.17 |
| iShares Core MSCI Total International Stock ETF | 587500 | 0.13 |
| Dimensional ETF Tr-Dimensional World ex U.S. Core Equity 2 ETF | 218000 | 0.05 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| Global X Aging Population ETF | 0.08785 | 20.37 | 1.46713 |
| First Trust Emerging Markets Small Cap AlphaDEX Fund | 0.01884 | 1061.14 | 2.70393 |
Vanguard FTSE All-World ex-US Small-Cap ETF
|
0.01 | 9.39 | 3.09932 |
SPDR S&P China ETF
|
0.0056 | 17.02 | 3.40103 |
| SPDR Portfolio MSCI Global Stock Market ETF | 0.00112 | 17.99 | 2.19607 |
| Avantis Responsible Emerging Markets Equity ETF | 0.00011 | 17.6 | 3.1719 |
| Avantis Emerging Markets Equity ETF | 0.0001 | 8.77 | 3.60513 |
| Vanguard ESG International Stock ETF | 0 | 6.39 | 3.07501 |
| 0.02 | 144.83 | 2.84 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Hou-Sen Lim MEng. | GM, COO & CTO | 1.37M | 1974 (51 year) |
| Joyce Heo | Director of Sales | N/A | |
| Mr. Christopher Lee Richardson | Head of U.S. Operations | N/A | 1962 (63 years) |
| Mr. Amir Gross | Head of Venus Global Heart Valve Innovation Center | N/A | |
| Shakeel Osman | Senior Vice President of Sales Europe | N/A | |
| Ms. Liu Meirong | Executive Director | N/A | 1976 (49 years) |
| Mr. Wai Chiu Wong FCS | Company Secretary | N/A | 1956 (69 years) |
| Mr. Fei Wang | Chief Financial Officer | N/A | 1978 (47 years) |
| Mr. Liqiao Ma | Executive Director | N/A |
Address: China, Hangzhou, No. 88 Jiangling Road - open in Google maps, open in Yandex maps
Website: https://www.venusmedtech.com
Website: https://www.venusmedtech.com
